Annals of internal medicine
-
Comment
In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin.
GRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075-88. 36129997.
-
In their article, Holmer and colleagues reported the final update of a living review that examined the duration of IgG antibody response, the role of previous SARS-CoV-2 infection to prevent reinfection, and the role of antibodies in protection from reinfection. The editorialist discusses the challenge of living reviews as new evidence emerges and the relevant clinical questions evolve.
-
Connolly SJ, Karthikeyan G, Ntsekhe M, et al. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N Engl J Med. 2022;387:978-88. 36036525.
-
Monkeypox, a viral zoonotic disease, is causing a global outbreak outside of endemic areas. ⋯ None.
-
Han MK, Ye W, Wang D, et al. Bronchodilators in tobacco-exposed persons with symptoms and preserved lung function. N Engl J Med. 2022;387:1173-84. 36066078.